Bioterrorism before and after September 11

Critical Reviews in Microbiology

Volumn 27, Issue 4, 2001, Pages 355-379

  Atlas, Ronald M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTHRAX VACCINE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; IMIPENEM; PENICILLIN DERIVATIVE; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

AEROSOL; ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; BACILLUS ANTHRACIS; BACTERIUM IDENTIFICATION; BIOLOGICAL WARFARE; DRUG MEGADOSE; FEAR; HUMAN; INHALATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; TERRORISM;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS);

EID: 0035692820     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.1080/20014091096783     Document Type: Review

References (68)

1. The silent killers
2. Microbes and mass casualties: Defending America against bioterrorism
3. The medical threat of biological weapons
4. Biological weapons: An increasing threat
5. Viruses, bacteria, and toxins as biological warfare
6. Bioterrorism as a public health threat
7. The looming threat of bioterrorism
8. Terrorism in America. An evolving threat
9. Catastrophic terrorism: Tackling the new danger
10. Why should we be concerned about biological warfare?
11. Anthrax: A possible case history
12. Applying lessons learned from anthrax case history to other scenarios
13. Potential biological weapons threats
14. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars
15. An outbreak of Shigella dysenteriae Type 2 among laboratory workers due to intentional contamination
16. Deliberate spreading of typhoid in Japan
17. Aum Shinrikyo: Once and future threat?
18. Bioterrorism alleging use of anthrax and interim guidelines for management US, 1998
19. California anthrax threats spawn costly wave of fear
20. Death at Sverdlovsk: A critical diagnosis
21. The Sverdlovsk anthrax outbreak of 1979
22. Death at Sverdlovsk: What have we learned?
23. Pathology of inhalational anthrax in forty-two cases from the Sverdlovsk outbreak of 1979
24. PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: The presence of multiple Bacillus anthracis strains in different victims
25. vrrB, a hypervariable open reading frame in Bacillus anthracis
26. Bioterrorism on the home front: A new challenge for American medicine
27. Clinical recognition and management of patients exposed to biological warfare agents
28. Anthrax as a potential biological warfare agent
29. Inhalational anthrax: Epidemiology, diagnosis, and management
30. Bacillus anthracis (anthrax)
31. Molecular pathogenesis of Bacillus anthracis infection
32. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes
33. Designing a polyvalent inhibitor of anthrax toxin
34. Inhalation anthrax
35. Inhalation anthrax in a home craftsman
36. Human inhalation anthrax: A report of three fatal cases
37. Case record #14032: An acute infection with bloody fluid in the right pleural space
38. An epidemic of inhalation anthrax: The first in the twentieth century. II. Epidemiology
39. Two cases of fatal inhalation anthrax, one associated with sarcoidosis
40. Anthrax: A report of one hundred seventeen cases
41. Epidemiologic study of a fatal case of inhalational anthrax
42. Woolsorter's disease in England
43. Inhalation anthrax meningitis and bacillemia: A case report
44. An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features
45. Cases from the medical grand rounds of the Massachusetts General Hospital, case 388: Sinusitis due to anthrax
46. Pulmonary anthrax: Report of a case
47. Primary pulmonary anthrax with septicemia
48. Anthrax
49. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax
50. Notice to readers: Considerations for distinguishing influenza-like illness from inhalational anthrax
51. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices
52. Interim guidelines for investigation of and response to Bacillus anthracis exposures
53. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis
54. Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates
55. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy
56. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States
57. Clinical presentation of inhalational anthrax following bioterrorism exposure report of 2 surviving patients
58. Death due to bioterrorism-related inhalational anthrax report of 2 patients
59. Historical trends related to bioterrorism: An empirical analysis